Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone Therapy in Pediatric Crohn's Disease
NCT00109473Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Apr 2005
- Primary completion
- Jul 2009
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of somatropin in Crohn's disease (2 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Crohn's Disease Histologic Index of Severity at 12 weeks. Started Apr 2005; status: completed.
02
Drugs
somatropin
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00109473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109473.